Kodiak Sciences Inc at JPMorgan Healthcare Conference Transcript
All right. Let's go ahead and get started. Welcome, everyone, to the Wednesday morning of the 41st Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Priyanka Grover and Malcolm Kuno from the team. Our next presenting company is Kodiak and presenting on behalf of the company, we have CEO, Victor Perlroth. Victor?
Thank you, Anupam. It's my pleasure to be here. Welcome to 2023. We have a large number of activities in progress and a lot of data that we're preparing, and we look forward to the progress of the year. Before we get started, let's remind that I may be making some forward-looking statements, so please refer carefully to risk factors in our SEC filings.
With all of the discussions going on in the field of biotech, maybe consternations. It's useful to remind ourselves where does Kodiak fit in. And I think we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
